U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07476534) titled 'Exploration Study of Molecular Biomarkers for Tumor-related Anxiety and Depression' on March 12.
Brief Summary: Identifying and validating molecular biomarkers associated with tumor-related anxiety and depression. By integrating psychological assessment data from clinical tumor patients with molecular detection results, and utilizing clinically accessible samples such as tumor tissues and sera from clinical cohorts, this study aims to clinically validate the tumor-derived proteins previously identified by our team as having potential regulatory roles. The goal is to clarify the clinical value of tumor-derived proteins as molecular ...